Navigation Links
Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial
Date:10/7/2008

jective of the study is to assess the overall tumor response rate to the combination of bavituximab with carboplatin and paclitaxel. Secondary objectives include measuring time to tumor progression, duration of response, overall patient survival and safety parameters. Patients enrolled in the trial are receiving up to six cycles of bavituximab in combination with carboplatin and paclitaxel. Patients may continue to receive bavituximab alone after completion of the combination regimen cycles as long as the cancer does not progress and side effects are acceptable. The trial is being conducted in India according to International Conference on Harmonization (ICH) and Good Clinical Practices (GCP) standards.

The World Health Organization reports that breast cancer is the most commonly diagnosed cancer in women, and is second only to lung cancer as a leading cause of female cancer deaths. The National Cancer Institute estimates that approximately 182,460 U.S. women will be diagnosed with breast cancer in 2008 and 40,480 women will die of the disease.

Bavituximab is a monoclonal antibody that binds to the cellular membrane component phosphatidylserine (PS) that is usually located inside cells, but which becomes exposed on the outside of the cells that line the blood vessels of tumors, creating a specific target for anti-cancer treatments. By binding to PS, bavituximab is believed to help mobilize the body's immune system to destroy the tumor and the tumor blood vessels. Bavituximab currently is in two separate Phase II combination therapy trials for the treatment of advanced breast cancer and a Phase II combination therapy trial for the treatment of NSCLC. A Phase I bavituximab monotherapy trial in advanced solid cancers is also continuing.

About Peregrine Pharmaceuticals

Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative product candidates in clinical trials for the treatment of cancer and hepatitis C
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
2. Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer
3. Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
4. Peregrine Pharmaceuticals Awarded Two New U.S. Patents Broadening Its Targeted Anti-Phospholipid Patent Portfolio
5. Data To Be Presented at ASCO Supports Potential of Peregrines Cotara(R) for the Treatment of Brain Cancer
6. Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Bavituximab Phase II Breast Cancer Trial
7. Peregrine Researchers Present New Preclinical Data at AACR Annual Meeting Confirming Unique Anti-Tumor Mechanism of Bavituximab
8. Preclinical Study Presented at AACR Annual Meeting Shows Peregrines Anti-PS Immunocytokines Can Generate Protective Immune Responses in a Highly Aggressive Breast Cancer Model
9. Preclinical Study Presented at AACR Annual Meeting Shows Broad Anti-Cancer Potential of Peregrines anti-PS Vascular Targeting Antibodies
10. Clinical Experience With Peregrines Anti-Cancer Agent Bavituximab Presented at Leading Symposium on Anti-Angiogenic Agents
11. Peregrine Pharmaceuticals Opens Enrollment in Phase II Clinical Trial of Bavituximab in Patients with Advanced Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... 27, 2015 Research ... addition of the  "2015 Strategies in the ... to their offering.       (Logo: ... contains 500 pages, 120 tables, and is ... market entrants identify and evaluate business opportunities ...
(Date:5/27/2015)... , May 27, 2015 PharmaPoint: Type 1 ... Summary Type 1 diabetes (T1D) is an autoimmune ... which means that the body can no longer produce insulin. ... continuously, as at present, no other treatment can be offered ... variety of insulin analogs with different times of action - ...
(Date:5/27/2015)... 2015 ... the addition of the  "2015 Strategies in ...  report to their offering.      ... to the US NAT laboratory practice, as ... and technological trends with significant market impact ...
Breaking Medicine Technology:European Hemostasis Diagnostic Testing Market Strategies 2015 2PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 2PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 3PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 4United States Nucleic Acid Testing Market Strategies 2015-2020 2
... SAN DIEGO , May 21 ... that it has received an Advanced Technology Small Business ... of Allergy and Infectious Diseases. The peer-reviewed grant was ... develop novel antibody therapeutics and vaccines to combat ...
... Results of two Phase II trials evaluating ALIMTA® (pemetrexed for injection) ... advanced non-small cell lung cancer (NSCLC) will be presented by Eli Lilly ... Clinical Oncology (ASCO) in Chicago, Ill. , on June 6, ... The standard ...
Cached Medicine Technology:Sorrento Therapeutics Awarded NIH Grant for MRSA Program 2Sorrento Therapeutics Awarded NIH Grant for MRSA Program 3Sorrento Therapeutics Awarded NIH Grant for MRSA Program 4Two Studies Evaluated Full-Dose Chemotherapy Regimen and Concurrent Radiation in Treatment of Lung Cancer 2Two Studies Evaluated Full-Dose Chemotherapy Regimen and Concurrent Radiation in Treatment of Lung Cancer 3Two Studies Evaluated Full-Dose Chemotherapy Regimen and Concurrent Radiation in Treatment of Lung Cancer 4Two Studies Evaluated Full-Dose Chemotherapy Regimen and Concurrent Radiation in Treatment of Lung Cancer 5Two Studies Evaluated Full-Dose Chemotherapy Regimen and Concurrent Radiation in Treatment of Lung Cancer 6Two Studies Evaluated Full-Dose Chemotherapy Regimen and Concurrent Radiation in Treatment of Lung Cancer 7Two Studies Evaluated Full-Dose Chemotherapy Regimen and Concurrent Radiation in Treatment of Lung Cancer 8
(Date:5/27/2015)... Cincinnati Veterans Affairs Women’s Health Clinic in ... Foundation is proud to host the first annual Women Veterans ... 11 at the Freedom Center from 6 p.m. to 10 ... emcee. , This event honors and celebrates women tri-state ... The banquet is free to the first 150 women Veterans ...
(Date:5/27/2015)... Phoenix, Arizona (PRWEB) May 27, 2015 ... use of their advanced programmatic marketing technology, they have ... provides advertising support on a regional level for seven ... Honda's marketing was through television and radio media. In ... and, with the help of Genius Monkey , ...
(Date:5/27/2015)... With InnerVoice Communication App you will be ... not only heard but seen -- by a photograph of ... This award-winning and affordable app takes full advantage of all ... InnerVoice Sender app in conjunction with InnerVoice Communication App, ... for no additional cost. , InnerVoice Sender allows ...
(Date:5/27/2015)... Iowa (PRWEB) May 27, 2015 With ... away, a poll conducted during the "ACA - Controlling ... poll participants, 75% are currently in the process of ... over 15% were confidently prepared for the reporting mandates. ... shown during the webinar, those who are currently vetting ...
(Date:5/27/2015)... 27, 2015 SmarterSkin, http://www.smarterskindermatology.com , is ... cutting-edge test that makes it easier for patients to find ... , Dr. Sejal Shah is a cosmetic dermatologist based ... to offer the test. This revolutionary DNA test uses 16 ... skin aging: , 1. Firmness and elasticity , ...
Breaking Medicine News(10 mins):Health News:Cincinnati VA Women’s Health Clinic Celebrates Women Veterans at Awards Banquet 2Health News:Genius Monkey Boosts Utah Honda Dealers Website Traffic 142% 2Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 2Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 3Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 4Health News:Employers are On Track for ACA Reporting According to Businessolver Poll 2Health News:SmarterSkin Dermatology is Now Offering Skin DNA Analysis 2
... performed worse and had stereotypical notions about boys, math prowess, ... elementary school teachers who are anxious about their math skills ... female students, new research suggests. , Girls in their classes ... at math. And at the end of the school year, ...
... , TOLEDO, Ohio , Jan. 25 ... insurance brokerage firms in the nation, and the W Group, ... to provide their clients with more personalized service and greater ... employee benefit firms in the Greater Cincinnati area. ...
... , , PITTSBURGH , Jan. 25 ... of Health Secretary Everette James and Secretary of Education ... boost physical activity among students. , "One-third of all Pennsylvania ... a lifetime of health problems," said James. "Schools like Avonworth are ...
... INDIANAPOLIS Research from a five-year international clinical study shows ... of the herpes virus, does not affect HIV transmission by ... the Partners in Prevention HSV/HIV Transmission Study, was released by ... online edition Jan. 20 and will follow in the print ...
... disinfectants can also prompt seat-linked skin woes, experts warn ... chemicals and wooden toilet seats -- especially those with ... why U.S. cases of toilet seat-related skin irritations among ... can develop toilet seat dermatitis after repeated exposure to ...
... , , ... OrthoAccel Technologies, Inc., developers of the AcceleDent System ... this week that it has engaged Waldemar "Val" B. ... with the Company will be primarily focused on strategic development ...
Cached Medicine News:Health News:Female Teachers Pass on Math Anxieties 2Health News:Female Teachers Pass on Math Anxieties 3Health News:Two of Cincinnati's Leading Employee Benefit Providers Merge to Offer Clients Greater Expertise and Service 2Health News:State Health, Education Leaders Hail Avonworth Middle School in Allegheny County for Boosting Physical Activity Among Students 2Health News:Control of herpes symptoms does not reduce HIV transmission, international study found 2Health News:Wooden Toilet Seats Can Trigger Children's Rash 2Health News:Industry Advisor Joins OrthoAccel Technologies, Inc. 2Health News:Industry Advisor Joins OrthoAccel Technologies, Inc. 3Health News:Industry Advisor Joins OrthoAccel Technologies, Inc. 4
... The Series I Instrument program offers ... low profile, while maintaining strength and durability. ... pathology in tight joint spaces. Series I ... cutting tip style, size and angle required ...
... program offers state-of-the-art quality in an instrument ... and durability. Low profile cutting tips allow ... Series I instruments are available in just ... angle required for large and small joint ...
... The Series I Instrument program offers ... low profile, while maintaining strength and durability. ... pathology in tight joint spaces. Series I ... cutting tip style, size and angle required ...
... facilitates fast and effective resection of meniscal ... meniscal rim. The flat, crescent-shaped tip has ... the tightest joint spaces. Made in the ... of engineering experience in arthroscopy hand instrument ...
Medicine Products: